Michael Kagnoff, Director at GenMark Diagnostics, Inc. (GNMK), bought 2,000 shares at $12.50 ($25K) on 2016-11-14, disclosed to the SEC on 2016-11-14.
Open-market purchase of $25k GNMK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| GNMK | BUY | 2017-11-06 | $83K | — | Filing → |
| GNMK | BUY | 2017-09-11 | $23K | — | Filing → |
| GNMK | BUY | 2016-11-22 | $24K | — | Filing → |